HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marion Wencker Selected Research

alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency)

8/2009Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.
10/2005Cytotoxic concentrations of alpha-defensins in the lungs of individuals with alpha 1-antitrypsin deficiency and moderate to severe lung disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marion Wencker Research Topics

Disease

5Chronic Obstructive Pulmonary Disease (COPD)
09/2017 - 08/2006
3Emphysema
01/2021 - 08/2009
2Disease Progression
01/2020 - 01/2017
2alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency)
08/2009 - 10/2005
1Liver Diseases (Liver Disease)
01/2020
1Asthma (Bronchial Asthma)
12/2008
1Lung Diseases (Lung Disease)
10/2005

Drug/Important Bio-Agent (IBA)

2alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA
01/2017 - 08/2009
1prednylidene (Pred)IBA
09/2017
1Peptide Hydrolases (Proteases)FDA Link
01/2017
1Salmeterol Xinafoate (Serevent)FDA Link
01/2007
1Fluticasone (Cutivate)FDA LinkGeneric
01/2007
1SteroidsIBA
08/2006
1GoldIBA
08/2006
1alpha-DefensinsIBA
10/2005

Therapy/Procedure

5Therapeutics
01/2021 - 01/2007
1Dry Powder Inhalers
12/2008